SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Damon Abilock who wrote (32)11/25/1996 3:40:00 PM
From: TheSlowLane   of 675
 
CNSI is on the move! It looks like interest is warming up on CNSI. It has hit 14 today. I talked to a friend of mine who is a glaucoma specialist. He says that it looks promising. If the drug is fundamentally the same s Cerestat, CNSI may be able to bring it to market quickly, bypassing clinical trials. Otherwise he thinks it will be years before they can market the glaucoma drug. He also commented that the fact that they are in Phase III with Cerestat was indicative that the drug has proven efficacy (to some extent) without major side effects. We'll see what happens next...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext